JPMorgan Chase & Co. Cuts Holdings in CME Group Inc (CME)

JPMorgan Chase & Co. reduced its holdings in CME Group Inc (NASDAQ:CME) by 2.2% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,152,554 shares of the financial services provider’s stock after selling 140,810 shares during the period. JPMorgan Chase & Co. owned about 1.81% of CME Group worth $835,886,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. ST Germain D J Co. Inc. purchased a new stake in CME Group in the third quarter valued at $232,000. Capital Advisors Inc. OK raised its holdings in shares of CME Group by 10.7% in the 2nd quarter. Capital Advisors Inc. OK now owns 84,533 shares of the financial services provider’s stock valued at $10,587,000 after buying an additional 8,198 shares during the period. Marvin & Palmer Associates Inc. raised its holdings in shares of CME Group by 100.7% in the 2nd quarter. Marvin & Palmer Associates Inc. now owns 57,278 shares of the financial services provider’s stock valued at $7,173,000 after buying an additional 28,745 shares during the period. Captrust Financial Advisors purchased a new stake in shares of CME Group in the 2nd quarter valued at $693,000. Finally, Commerce Bank raised its holdings in shares of CME Group by 3.8% in the 2nd quarter. Commerce Bank now owns 560,899 shares of the financial services provider’s stock valued at $70,247,000 after buying an additional 20,449 shares during the period. 83.17% of the stock is currently owned by institutional investors.

Shares of CME Group Inc (NASDAQ CME) opened at $152.11 on Wednesday. The firm has a market capitalization of $52,023.63, a P/E ratio of 32.09, a P/E/G ratio of 3.15 and a beta of 0.73. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group Inc has a fifty-two week low of $113.27 and a fifty-two week high of $155.29.

CME Group (NASDAQ:CME) last announced its earnings results on Thursday, October 26th. The financial services provider reported $1.19 EPS for the quarter, beating analysts’ consensus estimates of $1.16 by $0.03. The firm had revenue of $890.80 million for the quarter, compared to analysts’ expectations of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. CME Group’s quarterly revenue was up 5.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.05 EPS. analysts expect that CME Group Inc will post 4.78 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 27th. Stockholders of record on Friday, December 8th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 1.74%. The ex-dividend date is Thursday, December 7th. CME Group’s dividend payout ratio (DPR) is 59.86%.

CME has been the subject of several analyst reports. Citigroup boosted their target price on CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, October 19th. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, October 18th. UBS reaffirmed a “buy” rating and set a $135.00 price objective (up from $134.00) on shares of CME Group in a research report on Wednesday, September 6th. Keefe, Bruyette & Woods reissued a “hold” rating and issued a $127.00 target price on shares of CME Group in a research report on Friday, August 18th. Finally, Wells Fargo & Company upped their target price on CME Group from $130.00 to $145.00 and gave the company a “market perform” rating in a research report on Wednesday, October 4th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus target price of $141.75.

In other news, COO Julie Holzrichter sold 12,920 shares of the firm’s stock in a transaction on Tuesday, November 28th. The stock was sold at an average price of $144.08, for a total transaction of $1,861,513.60. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Dennis Suskind sold 750 shares of the firm’s stock in a transaction on Monday, September 11th. The stock was sold at an average price of $129.34, for a total value of $97,005.00. Following the sale, the director now owns 5,059 shares in the company, valued at approximately $654,331.06. The disclosure for this sale can be found here. Insiders have sold 34,921 shares of company stock worth $5,016,248 in the last 90 days. Insiders own 0.57% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was first posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this story on another site, it was stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this story can be read at https://stocknewstimes.com/2017/12/06/jpmorgan-chase-co-sells-140810-shares-of-cme-group-inc-cme.html.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply